New Delhi, 28 Aug 2023: Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).

The New Jersey-based arm of ......
View Details

Related News

• TSMC files 400 FIRs against quacks in Telangana (24-12-2024)

---

• District Collector issued instructions regarding Misused Banned Narcotic Drugs (24-12-2024)

---

• Dabur takes Patanjali to Delhi High Court over disparaging Chyawanprash ad (24-12-2024)

---

• PMO steps in, asks health ministry to act against misleading adverts (24-12-2024)

---

• AIIMS, Delhi developing low cost adaptive cellular therapy for treatment of multiple myeloma (24-12-2024)

---

• First Generic of Once-Daily GLP-1 Injection Approved for Diabetes (24-12-2024)

---

• US FDA approves Mesoblast's first-of-its-kind cell therapy (24-12-2024)

---

• Panel dismayed over poor response from DoP on removing bottlenecks in medical devices manufacturing (24-12-2024)

---

• Himachal HC denies bail for manufacturing spurious drugs to owner of Glenmars Healthcare (24-12-2024)

---

• US FDA restricts imports of 11 formulations of Viatris made at Indore facility (24-12-2024)

---